Analysis of Lung Gene Expression Reveals a Role for Cl- Channels in Diisocyanate Induced Airway Eosinophilia in a Mouse Model of Asthma Pathology
-
2020/07/01
-
Details
-
Personal Author:
-
Description:Diisocyanates are well-recognized causes of asthma. However, sensitized workers frequently lack diisocyanate-specific IgE, which complicates diagnosis and suggests the disease involves IgE-independent mechanisms. We used a mouse model of methylene diphenyl diisocyanate (MDI) asthma to identify biological pathways that may contribute to asthma pathogenesis. MDI sensitization and respiratory tract exposure were performed in Balb/c, transgenic B-cell (e.g., IgE)-deficient mice and a genetic background (C57BL/6)-matched strain. Eosinophils in airway fluid were quantitated by flow cytometry. Lung tissue gene expression was assessed using whole-genome mRNA microarrays. Informatic software was used to identify biological pathways affected by respiratory tract exposure and potential targets for disease intervention. Airway eosinophilia and changes (>1.5-fold; P value < 0.05) in expression of 192 genes occurred in all three mouse strains tested, with enrichment in chemokines and a pattern associated with alternatively activated monocytes/macrophages. CLCA1 (calcium-activated chloride channel regulator 1) was the most upregulated gene transcript (>100-fold) in all exposed mouse lungs versus controls, followed closely by SLC26A4, another transcript involved in Cl- conductance. Crofelemer, a U.S. Food and Drug Administration-approved Cl- channel inhibitor, reduced MDI exposure induction of airway eosinophilia, mucus, CLCA1, and other asthma-associated gene transcripts. Expression changes in a core set of genes occurs independent of IgE in a mouse model of chemical-induced airway eosinophilia. In addition to chemokines and alternatively activated monocytes/macrophages, the data suggest a crucial role for Cl- channels in diisocyanate asthma pathology and as a possible target for intervention. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:1044-1549
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Pages in Document:25-35
-
Volume:63
-
Issue:1
-
NIOSHTIC Number:nn:20059100
-
Citation:Am J Respir Cell Mol Biol 2020 Jul; 63(1):25-35
-
Email:adam.wisnewski@yale.edu
-
CAS Registry Number:
-
Federal Fiscal Year:2020
-
NORA Priority Area:
-
Performing Organization:Yale University, New Haven, Connecticut
-
Peer Reviewed:True
-
Start Date:20160801
-
Source Full Name:American Journal of Respiratory Cell and Molecular Biology
-
End Date:20200731
-
Collection(s):
-
Main Document Checksum:urn:sha-512:dca2fd870ce56ec361ab5ff8865dd676e792f0d0d88c663d384afa011352e2836cbaa0436d1c47fe16cdc72a7d8a177b8c6763b186d9a3d69e212a832f4e1ff1
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like